Absence of Evidence May Not Mean Evidence of Absence: Commentary on an article by Bernard H. van Duren, BEng, MBChB, DPhil, et al.: "The Effect of Perioperative Biologic Disease-Modifying Anti-Rheumatic Drugs on the Risk of Postoperative Complications. Surgical Site Infection, Delayed Wound Healing, and Disease Flares Following Orthopaedic Surgical Procedures"
- PMID: 36149246
- DOI: 10.2106/JBJS.21.01296
Absence of Evidence May Not Mean Evidence of Absence: Commentary on an article by Bernard H. van Duren, BEng, MBChB, DPhil, et al.: "The Effect of Perioperative Biologic Disease-Modifying Anti-Rheumatic Drugs on the Risk of Postoperative Complications. Surgical Site Infection, Delayed Wound Healing, and Disease Flares Following Orthopaedic Surgical Procedures"
Conflict of interest statement
Disclosure: The Disclosure of Potential Conflicts of Interest form is provided with the online version of the article (http://links.lww.com/JBJS/G908).
Comment on
-
The Effect of Perioperative Biologic Disease-Modifying Anti-Rheumatic Drugs on the Risk of Postoperative Complications: Surgical Site Infection, Delayed Wound Healing, and Disease Flares Following Orthopaedic Surgical Procedures.J Bone Joint Surg Am. 2022 Jun 15;104(12):1116-1126. doi: 10.2106/JBJS.21.00811. Epub 2022 Feb 17. J Bone Joint Surg Am. 2022. PMID: 35175994
References
-
- Lenguerrand E, Whitehouse MR, Beswick AD, Kunutsor SK, Foguet P, Porter M, Blom AW; National Joint Registry for England, Wales, Northern Ireland and the Isle of Man. Risk factors associated with revision for prosthetic joint infection following knee replacement: an observational cohort study from England and Wales. Lancet Infect Dis. 2019 Jun;19(6):589-600.
-
- Goodman SM, Springer B, Guyatt G, Abdel MP, Dasa V, George M, Gewurz-Singer O, Giles JT, Johnson B, Lee S, Mandl LA, Mont MA, Sculco P, Sporer S, Stryker L, Turgunbaev M, Brause B, Chen AF, Gililland J, Goodman M, Hurley-Rosenblatt A, Kirou K, Losina E, MacKenzie R, Michaud K, Mikuls T, Russell L, Sah A, Miller AS, Singh JA, Yates A. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. J Arthroplasty. 2017 Sep;32(9):2628-38.
-
- Ito H, Kojima M, Nishida K, Matsushita I, Kojima T, Nakayama T, Endo H, Hirata S, Kaneko Y, Kawahito Y, Kishimoto M, Seto Y, Kamatani N, Tsutani K, Igarashi A, Hasegawa M, Miyasaka N, Yamanaka H. Postoperative complications in patients with rheumatoid arthritis using a biological agent - A systematic review and meta-analysis. Mod Rheumatol. 2015 Sep;25(5):672-8.
-
- George MD, Baker JF, Hsu JY, Wu Q, Xie F, Chen L, Yun H, Curtis JR. Perioperative Timing of Infliximab and the Risk of Serious Infection After Elective Hip and Knee Arthroplasty. Arthritis Care Res (Hoboken). 2017 Dec;69(12):1845-54.
-
- George MD, Baker JF, Winthrop K, Alemao E, Chen L, Connolly S, Hsu JY, Simon TA, Wu Q, Xie F, Yang S, Curtis JR. Timing of Abatacept Before Elective Arthroplasty and Risk of Postoperative Outcomes. Arthritis Care Res (Hoboken). 2019 Sep;71(9):1224-33.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
